Effect of Low-Dose Celecoxib on SMN2 in Patients With Spinal Muscular Atrophy
Clinical trial NCT02876094 · TERMINATED
Trial details
- NCT number
- NCT02876094
- Sponsor
- Hugh McMillan
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-29
- Primary completion
- 2020-08-06
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.